We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$105B
1-Year Est. Return
38.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.69%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$90B
AUM Growth
-$2.64B
(-2.9%)
Cap. Flow
+$2.07B
Cap. Flow
% of AUM
2.3%
Top 10 Holdings %
Top 10 Hldgs %
17.41%
Holding
2,101
New
60
Increased
1,058
Reduced
623
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$327M |
| 2 |
Broadcom
AVGO
|
+$315M |
| 3 |
Mastercard
MA
|
+$262M |
| 4 |
Intuit
INTU
|
+$226M |
| 5 |
Digital Realty Trust
DLR
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$187M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$169M |
| 3 |
WCN
Waste Connections
WCN
|
+$141M |
| 4 |
NextEra Energy
NEE
|
+$134M |
| 5 |
Cadence Design Systems
CDNS
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.36% |
| 2 | Industrials | 16.63% |
| 3 | Healthcare | 13.3% |
| 4 | Financials | 8.12% |
| 5 | Consumer Discretionary | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Toll Brothers
TOL
$14.3B
| $70.1M | 0.08% |
663,700
-120,712
| -15% | -$14.5M |
|
252
Varonis Systems
VRNS
$4.84B
| $69.7M | 0.08% |
1,721,890
-565,654
| -25% | -$24.3M |
|
253
McCormick & Company Non-Voting
MKC
$14.2B
| $69.1M | 0.08% |
839,535
-223,153
| -21% | -$17.5M |
|
254
AutoZone
AZO
$49.7B
| $69M | 0.08% |
18,090
+2,722
| +18% | +$9.39M |
|
255
A.O. Smith
AOS
$8.65B
| $68.6M | 0.08% |
1,049,735
-64,470
| -6% | -$4.36M |
|
256
Madrigal Pharmaceuticals
MDGL
$12.4B
| $68.5M | 0.08% |
207,043
-1,441
| -0.7% | -$473K |
|
257
Aflac
AFL
$60.7B
| $67.9M | 0.08% |
610,561
-34,634
| -5% | -$3.67M |
|
258
Motorola Solutions
MSI
$77.3B
| $67.7M | 0.08% |
154,573
+48,876
| +46% | +$21.8M |
|
259
On Holding
ONON
$10.3B
| $67.3M | 0.07% |
1,532,000
+88,740
| +6% | +$4.66M |
|
260
Alibaba
BABA
$306B
| $66.7M | 0.07% |
504,644
+264,033
| +110% | +$30.4M |
|
|
CNH
261
CNH Industrial
CNH
$17.1B
| $65.8M | 0.07% |
5,360,415
-716,022
| -12% | -$8.98M |
|
262
Dick's Sporting Goods
DKS
$18.4B
| $64.3M | 0.07% |
318,849
-48,203
| -13% | -$10.8M |
|
263
Waters Corp
WAT
$40.7B
| $63.5M | 0.07% |
172,420
+133,735
| +346% | +$51.8M |
|
264
Intercontinental Exchange
ICE
$84.9B
| $63.5M | 0.07% |
368,307
-8,973
| -2% | -$1.47M |
|
265
Cognizant
CTSH
$26.4B
| $63.4M | 0.07% |
828,364
-40,008
| -5% | -$3.26M |
|
266
McKesson
MCK
$105B
| $63.3M | 0.07% |
94,099
+813
| +0.9% | +$503K |
|
267
T-Mobile US
TMUS
$192B
| $63.2M | 0.07% |
237,155
-7,918
| -3% | -$1.95M |
|
268
Live Nation Entertainment
LYV
$42.7B
| $63.2M | 0.07% |
483,659
+30,289
| +7% | +$4.14M |
|
269
Ulta Beauty
ULTA
$23.3B
| $63M | 0.07% |
171,913
+36,538
| +27% | +$13.9M |
|
270
Citigroup
C
$228B
| $62.7M | 0.07% |
883,271
-506
| -0.1% | -$38.6K |
|
271
Fidelity National Financial
FNF
$12.8B
| $62.3M | 0.07% |
956,807
-8,143
| -0.8% | -$489K |
|
272
Royal Bank of Canada
RY
$292B
| $62M | 0.07% |
550,209
+21,608
| +4% | +$2.54M |
|
273
United Therapeutics
UTHR
$22.1B
| $61.8M | 0.07% |
200,657
+82,566
| +70% | +$28.3M |
|
274
Chubb
CB
$134B
| $61M | 0.07% |
201,906
+11,328
| +6% | +$3.15M |
|
275
MongoDB
MDB
$35.3B
| $60.8M | 0.07% |
346,871
-10,093
| -3% | -$2.46M |
|
Similar funds
Pictet Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, Pictet Asset Management held 2,101 positions worth $90B, down 2.9% from $92.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Pictet Asset Management's Q1 2025 filing shows 60 new, 1,058 increased, 623 reduced and 92 closed positions. Its largest new stake was Verona Pharma: 703,063 shares worth $44.6M. The largest sale was Intra-Cellular Therapies Inc., an estimated $187M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Industrials and Healthcare.
- Pictet Asset Management's largest Q1 2025 buy was Verona Pharma: 703,063 shares worth $44.6M.
- Pictet Asset Management added most to Synopsys in Q1 2025, an estimated $327M increase.
- Pictet Asset Management's biggest Q1 2025 reduction was Intra-Cellular Therapies Inc., cutting an estimated $187M.
- Pictet Asset Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2025, selling an estimated $46.5M.
- Pictet Asset Management's ten largest holdings make up 17% of its $90B portfolio in Q1 2025.
- Pictet Asset Management opened 60 new positions and closed 92 in Q1 2025.
- Pictet Asset Management's portfolio value fell 2.9% quarter-over-quarter to $90B.
Based on Pictet Asset Management's 13F filing for Q1 2025, filed 5 May 2025.